ELISABETH RASCH: Open Payments
NPI 1770345068 · PUYALLUP, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$750 in 38 payments from 19 companies in 2025. Trend: 2023 $0 · 2024 $442 · 2025 $750
Food & beverage: $750
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $149 |
| Corcept Therapeutics | 3 | $74 |
| GlaxoSmithKline, LLC. | 3 | $67 |
| PFIZER INC. | 3 | $61 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $59 |
| Lilly USA, LLC | 2 | $57 |
| AstraZeneca Pharmaceuticals LP | 2 | $40 |
| ABBVIE INC. | 2 | $36 |
| Abbott Laboratories | 1 | $28 |
| Astellas Pharma US Inc | 1 | $25 |
Products named: Korlym, JARDIANCE, Rybelsus, SHINGRIX, Ozempic, CAPLYTA, BREZTRI, PREVNAR 20.
Industry payments across WA — which companies pay providers there.
